BETA BIONICS, INC. financials

BBNX CIK 0001674632

Source: EDGAR filings · Built 2026-06-02T02:26:06Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2024
Free Cash Flow -56.22M -51.67M -32.85M
EBITDA -70.11M -44.10M -34.62M
Working Capital 236.98M 111.78M 93.02M
Net Debt -24.17M -23.08M -22.34M
Gross Margin 55.40% 55.11% 52.59%
Operating Margin -71.50% -69.48% -298.87%
Net Margin -73.02% -84.08% -367.64%
Return on Equity (ROE) -25.45% 22.32% 21.71%
Return on Assets (ROA) -22.27% -36.59% -40.08%
Current Ratio 8.66× 6.29× 9.77×
Debt-to-Equity 0.03× -0.03× -0.02×
Cash Conversion Ratio 0.70× 0.88× 0.74×
Accruals Ratio -0.07× -0.04× -0.11×
SBC % of Revenue 16.34% 9.80% 47.17%
CapEx Coverage -9.61× -14.22× -80.71×
Free Cash Flow Per Share $-1.39 $-8.12 $-6.19

Valuation Metrics

Concept FY 2025FY 2024FY 2024
P/S 13.48×
P/B 4.70×

Income Statement

Concept FY 2025FY 2024FY 2024
Revenue from Contract with Customer, Excluding Assessed Tax 100.25M 65.12M 11.99M
Cost of Goods and Services Sold 44.71M 29.24M 5.69M
Gross Profit 55.54M 35.89M 6.31M
Research and Development Expense 34.79M 26.18M 17.94M
Operating Expenses 127.22M 81.14M 42.16M
Operating Income (Loss) -71.68M -45.25M -35.85M
Income Tax Expense (Benefit) 0 0
Net Income (Loss) Attributable to Parent -73.20M -54.76M -44.10M
Earnings Per Share, Basic $-1.81 $-8.60 $-8.31
Weighted Average Number of Shares Outstanding, Basic 40.53M 6.37M 5.30M
Earnings Per Share, Diluted $-1.81 $-8.60 $-8.31
Weighted Average Number of Shares Outstanding, Diluted 40.53M 6.37M 5.30M

Balance Sheet

Concept FY 2025FY 2024FY 2024
Cash and Cash Equivalents, at Carrying Value 31.58M 30.43M 26.57M
Assets, Current 267.90M 132.92M 103.62M
Assets 328.74M 149.65M 110.04M
Liabilities, Current 30.92M 21.15M 10.61M
Liabilities 41.13M 73.63M 51.43M
Stockholders' Equity Attributable to Parent 287.61M -245.36M -203.10M
Common Stock, Shares, Outstanding 44.36M 6.67M

Cash Flow Statement

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (BBNX CIK 0001674632), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CCB

COASTAL FINANCIAL CORPORATION

KRYS

Krystal Biotech, Inc.

SPRU

Spruce Power Holding Corporation